When you buy through links on our articles, Future and its syndication partners may earn a commission.
Mice injected with a microRNA molecule lived longer and had fewer markers of ageing, but it’s not yet known if the treatment ...
In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...
The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal ...
Highlights from the first day included updates from several firms about their China businesses and M&A strategies.
ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China ImmuneOnc ...
On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and ...